Lexpos News

/Lexpos News

MHRA Class 2 Medicines Recall: Itraconazole 10mg/ml Oral Solution (Kent Pharma UK)

Drug alert number: EL (24)A/26 Date issued: 04 July 2024 Kent Pharma UK is recalling various batches of Itraconazole 10mg/ml Oral Solution as a precautionary measure due to out of specification in the appearance of the solution, particularly the presence of suspended particles or clusters of crystals: Itraconazole 10mg/ml Oral Solution (Kent Pharma UK) PL [...]

The post MHRA Class 2 Medicines Recall: Itraconazole 10mg/ml Oral Solution (Kent Pharma UK) appeared first on Community Pharmacy England.

By |July 4th, 2024|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Itraconazole 10mg/ml Oral Solution (Kent Pharma UK)

July 2024 reimbursement price change for Naltrexone 50mg tablets

The Department of Health and Social Care (DHSC) has redetermined the July 2024 reimbursement price for Naltrexone 50mg tablets (28) listed in Category A of the Drug Tariff. The basic price for this product should be £82.15 instead of £774.23 as published in the July Drug Tariff. This pricing issue was caused by a data [...]

The post July 2024 reimbursement price change for Naltrexone 50mg tablets appeared first on Community Pharmacy England.

By |July 4th, 2024|Lexpos News|Comments Off on July 2024 reimbursement price change for Naltrexone 50mg tablets

Pharmacy First Update: A message from our CEO

Community Pharmacy England CEO Janet Morrison has given a video update on Pharmacy First, addressing some of the concerns that pharmacy owners have, particularly around the thresholds for monthly payments. In her video message, Janet notes the incredible early achievements of Pharmacy First as well as outlining the importance of the service and how it [...]

The post Pharmacy First Update: A message from our CEO appeared first on Community Pharmacy England.

By |July 2nd, 2024|Lexpos News|Comments Off on Pharmacy First Update: A message from our CEO

MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd)

Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) Drug alert number: EL (24)A/25 Date issued: 02 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) [...]

The post MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) appeared first on Community Pharmacy England.

By |July 2nd, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd)

DHSC’s June 2024 Price Concessions – Final Update

The Department of Health and Social Care (DHSC) has today (02/07/2024) confirmed the following list of final price concessions for June 2024. This announcement comes in the following month and follows the decision by DHSC to impose changes to concessions pricing from April 2024 to try to manage purchase margins. DHSC has applied its new margin reduction formula as [...]

The post DHSC’s June 2024 Price Concessions – Final Update appeared first on Community Pharmacy England.

By |July 2nd, 2024|Lexpos News|Comments Off on DHSC’s June 2024 Price Concessions – Final Update